Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss-Reference-Cited by-同舟云学术

Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss

Published:2009 Issue:7 Volume:32 Page:1193-1198
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kwak Han Bok¹,Kim Jong Yun²,Kim Kwang Jin¹,Choi Min-Kye¹,Kim Jeong-Joong¹,Kim Kwang Mee¹,Shin Yong-Il³,Lee Myeung Su⁴,Kim Hun Soo⁵,Kim Jeung Woo²,Chun Chul Hong²,Cho Hae Joong⁶,Hong Gi Youn⁶,Juhng Seon Kwan⁷,Yoon Kwon Ha⁷,Park Byoung Hyun⁸,Bae Ji Myung⁹,Han Joung-Kyue¹⁰,Oh Jaemin¹

Affiliation:

1. Department of Anatomy, School of Medicine, Wonkwang University

2. Department of Orthopedic Surgery, School of Medicine, Wonkwang University

3. Department of Physical Medicine and Rehabilitation, School of Medicine, Wonkwang University

4. Department of Rheumatology, School of Medicine, Wonkwang University

5. Department of Pathology, School of Medicine, Wonkwang University

6. Department of Obstetrics and Gynecology, School of Medicine, Wonkwang University

7. Department of Radiology, School of Medicine, Wonkwang University

8. Department of Endocrinology, School of Medicine, Wonkwang University

9. Department of Biomaterials, School of Dentistry, Wonkwang University

10. Department of Physical Education, Chung-Ang University

Publisher